<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="consistent with existing copyright protections.KHVI_0_1735227.pdf Abstract ABSTRACT The novel coronavirus" exact="infection" post="(COVID-19 or Coronavirus disease 2019) that emerged from Wuhan,"/>
 <result pre="in the past decades. However, to date, no licensed antiviral" exact="treatment" post="or vaccine exists for MERS and SARS. Most of"/>
 <result pre="Neither vaccines nor direct-acting antiviral drugs are available for the" exact="treatment" post="of human and animal coronavirus infections.2-4 Many efforts have"/>
 <result pre="for treating secondary bacterial infections. The WHO also recommends the" exact="isolation" post="of patients suspected or confirmed for COVID-19.16 The major"/>
 <result pre="a major role in the induction of protective immunity during" exact="infection" post="with SARS-CoV by eliciting neutralizing-antibodies and T-cell responses.19 Thus,"/>
 <result pre="vaccine platform technology. This vaccine is expected to undergo clinical" exact="testing" post="in the coming months.35 Passive immunization Direct administration of"/>
 <result pre="safe, non-immunogenic, broadly effective passive immunization of CoV-exposed subjects and" exact="treatment" post="of infected patients. Animal models for vaccine evaluation Suitable"/>
 <result pre="of these species. Small animals (mice or hamsters) resisting natural" exact="infection" post="with MERS-CoVs (which are susceptible to SARS-CoV) have been"/>
 <result pre="CRISPR-Cas9 gene-editing tool could make the animals susceptible to CoV" exact="infection" post="and virus replication.56 Genetic engineering was used in the"/>
 <result pre="permissive cells or transfected cells that overexpress virus receptors.59,61,62 SARS-CoV-2" exact="isolation" post="has been attempted in Vero and the Huh-7 cells"/>
 <result pre="infection.66 Because respiratory mucosa is the initial site in CoV" exact="infection" post="and transmission, mucosal immunization, such as using intranasal vaccine,67"/>
 <result pre="COVID-19 since higher concentrations were required to reduce the viral" exact="infection" post="in vitro. Both remdesivir and chloroquine are being used"/>
 <result pre="vitro. Both remdesivir and chloroquine are being used for the" exact="treatment" post="of other diseases and have a well-defined safety profile."/>
 <result pre="statement of the coronavirus study group. BioRxiv. 20202020.02.07.937862. doi:10.1101/2020.02.07.937862. 2.LuH.Drug" exact="treatment" post="options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020."/>
 <result pre="al., collab: HKU/UCH SARS Study GroupRole of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252–56."/>
 <result pre="Pharm. 2020;70(2):145–59. doi:10.2478/acph-2020-0024.31955138 16.collab: WHOClinical management of severe acute respiratory" exact="infection" post="when novel coronavirus (nCoV) infection is suspected; 2020[accessed 2020"/>
 <result pre="management of severe acute respiratory infection when novel coronavirus (nCoV)" exact="infection" post="is suspected; 2020[accessed 2020 215]https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected 17.LiH, WangYM, XuJY, CaoBPotential"/>
 <result pre="MorseJS, LalondeT, XuSLearning from the past: possible urgent prevention and" exact="treatment" post="options for severe acute respiratory infections caused by 2019-nCoV."/>
 <result pre="TengY, WuM, LiJ, LiY, HuN, WangH, et alEpitope-based vaccine target" exact="screening" post="against highly pathogenic MERS-CoV: an in silico approach applied"/>
 <result pre="KuikenT, FouchierRA, RimmelzwaanGF, Van AmerongenG, PeirisJS, LimW, OsterhausADVirology: SARS virus" exact="infection" post="of cats and ferrets. Nature. 2003;425(6961):915. doi:10.1038/425915a.14586458 45.RobertsA, WoodJ,"/>
 <result pre="MorikawaSEvaluation of a novel vesicular stomatitis virus pseudotype-based assay for" exact="detection" post="of neutralizing antibody responses to SARS-CoV. J Med Virol."/>
 <result pre="(2019-nCoV) in vitro. Cell Res. 2020a. doi:10.1038/s41422-020-0282-0. 64.KilianskiA, BakerSCCell-based antiviral" exact="screening" post="against coronaviruses: developing virus-specific and broad-spectrum inhibitors. Antiviral Res."/>
 <result pre="et alTreatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV" exact="infection" post="in a nonhuman primate model of common marmoset. J"/>
 <result pre="2020b;395:470–73. S0140-6736(20)30185-9. doi:10.1016/S0140-6736(20)30185-9.31986257 77.ChengVCC, WongSC, ToKKW, HoPL, YuenKYPreparedness and proactive" exact="infection" post="control measures against the emerging Wuhan coronavirus pneumonia in"/>
</results>
